Your request to link to rcsb for Protein-tyrosine phosphatase 1B

---

• 1ECV: crystal structure of protein tyrosine phosphatase 1b complexed with 5- iodo-2-(oxalyl-amino)-benzoic acid (10.1074/JBC.275.10.7101 )
• 1EEN: crystal structure of protein tyrosine phosphatase 1b complexed with acetyl-d-a-d-bpa-ptyr-l-i-p-q-q-g (10.1021/BI000319W )
• 1EEO: crystal structure of protein tyrosine phosphatase 1b complexed with acetyl-e-l-e-f-ptyr-m-d-y-e-nh2 (10.1021/BI000319W )
• 1G1F: crystal structure of protein tyrosine phosphatase 1b complexed with a tri-phosphorylated peptide (rdi(ptr) etd(ptr)(ptr)rk) from the insulin receptor kinase (10.1016/S1097-2765(00)00137-4 )
• 1G1G: crystal structure of protein tyrosine phosphatase 1b complexed with a mono-phosphorylated peptide (etdy(ptr) rkggkgll) from the insulin receptor kinase (10.1016/S1097-2765(00)00137-4 )
• 1G1H: crystal structure of protein tyrosine phosphatase 1b complexed with a bis-phosphorylated peptide (etd(ptr)(ptr) rkggkgll) from the insulin receptor kinase (10.1016/S1097-2765(00)00137-4 )
• 1G7F: human ptp1b catalytic domain complexed with pnu177496 (10.1021/BI002865V )
• 1G7G: human ptp1b catalytic domain complexes with pnu179326 (10.1021/BI002865V )
• 1GFY: residue 259 is a key determinant of substrate specificity of protein- tyrosine phosphatase 1b and alpha (10.1074/JBC.M910273199 )
• 1I57: crystal structure of apo human ptp1b (c215s) mutant (10.1110/PS.11001 )
• 1JF7: human ptp1b catalytic domain complexed with pnu177836 (10.1021/JM010393S )
• 1KAK: human tyrosine phosphatase 1b complexed with an inhibitor (10.1021/JM010266W )
• 1KAV: human tyrosine phosphatase 1b complexed with an inhibitor (10.1021/JM010266W )
• 1L8G: crystal structure of ptp1b complexed with 7-(1,1-dioxo-1h- benzo[d]isothiazol-3-yloxymethyl)-2-(oxalyl-amino)-4,7- dihydro-5h-thieno[2,3-c]pyran-3-carboxylic acid (10.1021/BI011389L )
• 1LQF: structure of ptp1b in complex with a peptidic bisphosphonate inhibitor (10.1021/BI0259554 )
• 1NL9: potent, selective protein tyrosine phosphatase 1b inhibitor compound 12 using a linked-fragment strategy (10.1021/JA0296733 )
• 1NNY: potent, selective protein tyrosine phosphatase 1b inhibitor compound 23 using a linked-fragment strategy (10.1021/JA0296733 )
• 1NO6: potent, selective protein tyrosine phosphatase 1b inhibitor compound 5 using a linked-fragment strategy (10.1021/JA0296733 )
• 1NWE: ptp1b r47c modified at c47 with n-[4-(2-{2-[3-(2-bromo-acetylamino)- propionylamino]-3-hydroxy-propionylamino}-ethyl)-phenyl]-oxalamic acid (10.1021/JA034440C )
• 1NWL: crystal structure of the ptp1b complexed with sp7343-sp7964, a ptyr mimetic (10.1021/JA034440C )
• 1NZ7: potent, selective inhibitors of protein tyrosine phosphatase 1b using a second phosphotyrosine binding site, complexed with compound 19. (10.1016/S0960-894X(03)00302-0 )
• 1OEM: ptp1b with the catalytic cysteine oxidized to a sulfenyl-amide bond (10.1038/NATURE01680 )
• 1OEO: ptp1b with the catalytic cysteine oxidized to sulfonic acid (10.1038/NATURE01680 )
• 1OES: oxidation state of protein tyrosine phosphatase 1b (10.1038/NATURE01681 )
• 1OET: oxidation state of protein tyrosine phosphatase 1b (10.1038/NATURE01681 )
• 1OEU: oxidation state of protein tyrosine phosphatase 1b (10.1038/NATURE01681 )
• 1OEV: oxidation state of protein tyrosine phosphatase 1b (10.1038/NATURE01681 )
• 1ONY: oxalyl-aryl-amino benzoic acid inhibitors of ptp1b, compound 17 (10.1021/JM0205696 )
• 1ONZ: oxalyl-aryl-amino benzoic acid inhibitors of ptp1b, compound 8b (10.1021/JM0205696 )
• 1PA1: crystal structure of the c215d mutant of protein tyrosine phosphatase 1b (10.1074/JBC.M303817200 )
• 1PH0: non-carboxylic acid-containing inhibitor of ptp1b targeting the second phosphotyrosine site (10.1021/JM034088D )
• 1PTT: crystal structure of protein tyrosine phosphatase 1b complexed with phosphotyrosine-containing tetra-peptide (ac-depyl-nh2)
• 1PTU: crystal structure of protein tyrosine phosphatase 1b complexed with phosphotyrosine-containing hexa-peptide (dadepyl-nh2)
• 1PTV: crystal structure of protein tyrosine phosphatase 1b complexed with phosphotyrosine
• 1PTY: crystal structure of protein tyrosine phosphatase 1b complexed with two phosphotyrosine molecules (10.1073/PNAS.94.25.13420 )
• 1PXH: crystal structure of protein tyrosine phosphatase 1b with potent and selective bidentate inhibitor compound 2 (10.1074/JBC.M212491200 )
• 1PYN: dual-site potent, selective protein tyrosine phosphatase 1b inhibitor using a linked fragment strategy and a malonate head on the first site (10.1016/S0960-894X(03)00725-X )
• 1Q1M: a highly efficient approach to a selective and cell active ptp1b inhibitors (10.1021/JM034122O )
• 1Q6J: the structure of phosphotyrosine phosphatase 1b in complex with compound 2 (10.1021/BI035098J )
• 1Q6M: the structure of phosphotyrosine phosphatase 1b in complex with compound 3 (10.1021/BI035098J )
• 1Q6N: the structure of phosphotyrosine phosphatase 1b in complex with compound 4 (10.1021/BI035098J )
• 1Q6P: the structure of phosphotyrosine phosphatase 1b in complex with compound 6 (10.1021/BI035098J )
• 1Q6S: the structure of phosphotyrosine phosphatase 1b in complex with compound 9 (10.1021/BI035098J )
• 1Q6T: the structure of phosphotyrosine phosphatase 1b in complex with compound 11 (10.1021/BI035098J )
• 1QXK: monoacid-based, cell permeable, selective inhibitors of protein tyrosine phosphatase 1b (10.1016/J.BMCL.2003.08.064 )
• 1SUG: 1.95 a structure of apo protein tyrosine phosphatase 1b (10.1107/S0907444904015094 )
• 1T48: allosteric inhibition of protein tyrosine phosphatase 1b (10.1038/NSMB803 )
• 1T49: allosteric inhibition of protein tyrosine phosphatase 1b (10.1038/NSMB803 )
• 1T4J: allosteric inhibition of protein tyrosine phosphatase 1b (10.1038/NSMB803 )
• 1WAX: protein tyrosine phosphatase 1b with active site inhibitor (10.1021/JM0495778 )
• 1XBO: ptp1b complexed with isoxazole carboxylic acid (10.1016/J.BMCL.2004.08.063 )
• 2AZR: crystal structure of ptp1b with bicyclic thiophene inhibitor (10.1016/J.BMC.2005.11.005 )
• 2B07: crystal structure of ptp1b with tricyclic thiophene inhibitor. (10.1016/J.BMC.2005.11.005 )
• 2B4S: crystal structure of a complex between ptp1b and the insulin receptor tyrosine kinase (10.1016/J.STR.2005.07.019 )
• 2BGD: structure-based design of protein tyrosine phosphatase-1b inhibitors (10.1016/J.BMCL.2005.03.068 )
• 2BGE: structure-based design of protein tyrosine phosphatase-1b inhibitors (10.1016/J.BMCL.2005.03.068 )
• 2CM2: structure of protein tyrosine phosphatase 1b (p212121) (10.1074/JBC.M606873200 )
• 2CM3: structure of protein tyrosine phosphatase 1b (c2) (10.1074/JBC.M606873200 )
• 2CM7: structural basis for inhibition of protein tyrosine phosphatase 1b by isothiazolidinone heterocyclic phosphonate mimetics (10.1074/JBC.M606873200 )
• 2CM8: structural basis for inhibition of protein tyrosine phosphatase 1b by isothiazolidinone heterocyclic phosphonate mimetics (10.1074/JBC.M606873200 )
• 2CMA: structural basis for inhibition of protein tyrosine phosphatase 1b by isothiazolidinone heterocyclic phosphonate mimetics (10.1074/JBC.M606873200 )
• 2CMB: structural basis for inhibition of protein tyrosine phosphatase 1b by isothiazolidinone heterocyclic phosphonate mimetics (10.1074/JBC.M606873200 )
• 2CMC: structural basis for inhibition of protein tyrosine phosphatase 1b by isothiazolidinone heterocyclic phosphonate mimetics (10.1074/JBC.M606873200 )
• 2CNE: structural insights into the design of nonpeptidic isothiazolidinone- containing inhibitors of protein tyrosine phosphatase 1b (10.1074/JBC.M607913200 )
• 2CNF: structural insights into the design of nonpeptidic isothiazolidinone- containing inhibitors of protein tyrosine phosphatase 1b (10.1074/JBC.M607913200 )
• 2CNG: structural insights into the design of nonpeptidic isothiazolidinone- containing inhibitors of protein tyrosine phosphatase 1b (10.1074/JBC.M607913200 )
• 2CNH: structural insights into the design of nonpeptidic isothiazolidinone- containing inhibitors of protein tyrosine phosphatase 1b (10.1074/JBC.M607913200 )
• 2CNI: structural insights into the design of nonpeptidic isothiazolidinone- containing inhibitors of protein tyrosine phosphatase 1b (10.1074/JBC.M607913200 )
• 2F6F: the structure of the s295f mutant of human ptp1b (10.1074/JBC.M511546200 )
• 2F6T: protein tyrosine phosphatase 1b with sulfamic acid inhibitors (10.1016/J.BMCL.2005.12.051 )
• 2F6V: protein tyrosine phosphatase 1b with sulfamic acid inhibitors (10.1016/J.BMCL.2005.12.051 )
• 2F6W: protein tyrosine phosphatase 1b with sulfamic acid inhibitors (10.1016/J.BMCL.2005.12.051 )
• 2F6Y: protein tyrosine phosphatase 1b with sulfamic acid inhibitors (10.1016/J.BMCL.2005.12.051 )
• 2F6Z: protein tyrosine phosphatase 1b with sulfamic acid inhibitors (10.1016/J.BMCL.2005.12.051 )
• 2F70: protein tyrosine phosphatase 1b with sulfamic acid inhibitors (10.1016/J.BMCL.2005.12.051 )
• 2F71: protein tyrosine phosphatase 1b with sulfamic acid inhibitors (10.1016/J.BMCL.2005.12.051 )
• 2FJM: the structure of phosphotyrosine phosphatase 1b in complex with compound 2 (10.1074/JBC.M511827200 )
• 2FJN: the structure of phosphotyrosine phosphatase 1b in complex with compound 2 (10.1074/JBC.M511827200 )
• 2H4G: crystal structure of ptp1b with monocyclic thiophene inhibitor (10.1016/J.BMCL.2006.06.051 )
• 2H4K: crystal structure of ptp1b with a monocyclic thiophene inhibitor (10.1016/J.BMCL.2006.06.051 )
• 2HB1: crystal structure of ptp1b with monocyclic thiophene inhibitor (10.1016/J.BMCL.2006.06.051 )
• 2HNP: crystal structure of human protein tyrosine phosphatase 1b
• 2HNQ: crystal structure of human protein tyrosine phosphatase 1b
• 2NT7: crystal structure of ptp1b-inhibitor complex (10.1016/J.BMCL.2007.02.043 )
• 2NTA: crystal structure of ptp1b-inhibitor complex (10.1016/J.BMCL.2007.02.043 )
• 2QBP: crystal structure of ptp1b-inhibitor complex (10.1021/JM0702478 )
• 2QBQ: crystal structure of ptp1b-inhibitor complex (10.1021/JM0702478 )
• 2QBR: crystal structure of ptp1b-inhibitor complex (10.1021/JM0702478 )
• 2QBS: crystal structure of ptp1b-inhibitor complex (10.1021/JM0702478 )
• 2VEU: crystal structure of protein tyrosine phosphatase 1b in complex with an isothiazolidinone-containing inhibitor (10.1016/J.BMCL.2007.11.012 )
• 2VEV: crystal structure of protein tyrosine phosphatase 1b in complex with an isothiazolidinone-containing inhibitor (10.1016/J.BMCL.2007.11.012 )
• 2VEW: crystal structure of protein tyrosine phosphatase 1b in complex with an isothiazolidinone-containing inhibitor (10.1016/J.BMCL.2007.11.012 )
• 2VEX: crystal structure of protein tyrosine phosphatase 1b in complex with an isothiazolidinone-containing inhibitor (10.1016/J.BMCL.2007.11.012 )
• 2VEY: crystal structure of protein tyrosine phosphatase 1b in complex with an isothiazolidinone-containing inhibitor 18-nov-20 2vey 1 title (10.1016/J.BMCL.2007.11.012 )
• 2ZMM: crystal structure of ptp1b-inhibitor complex (10.1002/CMDC.200800188 )
• 2ZN7: crystal structures of ptp1b-inhibitor complexes (10.1002/CMDC.200800188 )
• 3A5J: crystal structure of protein-tyrosine phosphatase 1b
• 3A5K: crystal structure of protein-tyrosine phosphatase 1b
• 3CWE: ptp1b in complex with a phosphonic acid inhibitor (10.1016/J.BMCL.2008.04.064 )
• 3D9C: crystal structure ptp1b complex with aryl seleninic acid (10.1021/JA804489M )
• 3EAX: crystal structure ptp1b complex with small molecule compound lzp-6 (10.1021/JA8068177 )
• 3EB1: crystal structure ptp1b complex with small molecule inhibitor lzp-25 (10.1021/JA8068177 )
• 3EU0: crystal structure of the s-nitrosylated cys215 of ptp1b (10.1074/JBC.M805287200 )
• 3I7Z: protein tyrosine phosphatase 1b - transition state analog for the first catalytic step (10.1074/JBC.M109.066951 )
• 3I80: protein tyrosine phosphatase 1b - transition state analog for the second catalytic step (10.1074/JBC.M109.066951 )
• 3QKP: protein tyrosine phosphatase 1b - apo w179f mutant with open wpd-loop (10.1016/J.ABB.2012.06.002 )
• 3QKQ: protein tyrosine phosphatase 1b - w179f mutant bound with vanadate (10.1016/J.ABB.2012.06.002 )
• 3SME: structure of ptp1b inactivated by h2o2/bicarbonate (10.1021/JA2077137 )
• 3ZMP: src-derived peptide inhibitor complex of ptp1b (10.1021/CB400903U )
• 3ZMQ: src-derived mutant peptide inhibitor complex of ptp1b (10.1021/CB400903U )
• 3ZV2: human protein-tyrosine phosphatase 1b c215a, s216a mutant (10.1016/J.CELL.2011.08.036 )
• 4BJO: nitrate in the active site of ptp1b is a putative mimetic of the transition state (10.1107/S1399004713031052 )
• 4I8N: crystal structure of protein tyrosine phosphatase 1b in complex with an inhibitor [(4-{(2s)-2-(1,3-benzoxazol-2-yl)-2-[(4-fluorophenyl) sulfamoyl]ethyl}phenyl)amino](oxo)acetic acid
• 4QAH: the second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop (10.1016/J.BIOCEL.2014.10.004 )
• 4QAP: the second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop (10.1016/J.BIOCEL.2014.10.004 )
• 4QBE: the second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop (10.1016/J.BIOCEL.2014.10.004 )
• 4QBW: the second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop (10.1016/J.BIOCEL.2014.10.004 )
• 4Y14: structure of protein tyrosine phosphatase 1b complexed with inhibitor (ptp1b:cpt157633) (10.1172/JCI80323 )
• 4ZRT: ptp1bc215s bound to nephrin peptide substrate (10.1021/BI401223R )
• 5K9V: protein tyrosine phosphatase 1b (1-301), open state (10.1016/J.MOLCEL.2017.01.014 )
• 5K9W: protein tyrosine phosphatase 1b (1-301) in complex with tcs401, closed state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA0: protein tyrosine phosphatase 1b delta helix 7, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA1: protein tyrosine phosphatase 1b delta helix 7 mutant in complex with tcs401, closed state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA2: protein tyrosine phosphatase 1b yaya (y152a, y153a) mutant, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA3: protein tyrosine phosphatase 1b yaya (y152a, y153a) mutant in complex with tcs401, closed state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA4: protein tyrosine phosphatase 1b t178a mutant, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA7: protein tyrosine phosphatase 1b t178a mutant in complex with tcs401, closed state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA8: protein tyrosine phosphatase 1b l192a mutant, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KA9: protein tyrosine phosphatase 1b l192a mutant in complex with tcs401, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KAA: protein tyrosine phosphatase 1b delta helix 7, p185g mutant, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KAB: protein tyrosine phosphatase 1b delta helix 7, p185g mutant in complex with tcs401, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KAC: protein tyrosine phosphatase 1b p185g mutant, open state (10.1016/J.MOLCEL.2017.01.014 )
• 5KAD: protein tyrosine phosphatase 1b n193a mutant in complex with tcs401, closed state (10.1016/J.MOLCEL.2017.01.014 )
• 5QDE: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000740a (10.7554/ELIFE.36307 )
• 5QDF: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000295a (10.7554/ELIFE.36307 )
• 5QDG: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000294a (10.7554/ELIFE.36307 )
• 5QDH: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000004a (10.7554/ELIFE.36307 )
• 5QDI: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000157a (10.7554/ELIFE.36307 )
• 5QDJ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000211a (10.7554/ELIFE.36307 )
• 5QDK: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000069a (10.7554/ELIFE.36307 )
• 5QDL: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000072a (10.7554/ELIFE.36307 )
• 5QDM: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000074a (10.7554/ELIFE.36307 )
• 5QDN: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000163a (10.7554/ELIFE.36307 )
• 5QDO: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmocr000171b (10.7554/ELIFE.36307 )
• 5QDP: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000207a (10.7554/ELIFE.36307 )
• 5QDQ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000847b (10.7554/ELIFE.36307 )
• 5QDR: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000089a (10.7554/ELIFE.36307 )
• 5QDS: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000108a (10.7554/ELIFE.36307 )
• 5QDT: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000475a (10.7554/ELIFE.36307 )
• 5QDU: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000466a (10.7554/ELIFE.36307 )
• 5QDV: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000574a (10.7554/ELIFE.36307 )
• 5QDW: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000465a (10.7554/ELIFE.36307 )
• 5QDX: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000484a (10.7554/ELIFE.36307 )
• 5QDY: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000599c (10.7554/ELIFE.36307 )
• 5QDZ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000435a (10.7554/ELIFE.36307 )
• 5QE0: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000648a (10.7554/ELIFE.36307 )
• 5QE1: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000645a (10.7554/ELIFE.36307 )
• 5QE2: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000398a (10.7554/ELIFE.36307 )
• 5QE3: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000449a (10.7554/ELIFE.36307 )
• 5QE4: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000514a (10.7554/ELIFE.36307 )
• 5QE5: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000632a (10.7554/ELIFE.36307 )
• 5QE6: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000608a (10.7554/ELIFE.36307 )
• 5QE7: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000601a (10.7554/ELIFE.36307 )
• 5QE8: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000127a (10.7554/ELIFE.36307 )
• 5QE9: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000232a (10.7554/ELIFE.36307 )
• 5QEA: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000733a (10.7554/ELIFE.36307 )
• 5QEB: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000639a (10.7554/ELIFE.36307 )
• 5QEC: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000270a (10.7554/ELIFE.36307 )
• 5QED: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000538a (10.7554/ELIFE.36307 )
• 5QEE: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000240a (10.7554/ELIFE.36307 )
• 5QEF: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000134a (10.7554/ELIFE.36307 )
• 5QEG: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000278a (10.7554/ELIFE.36307 )
• 5QEH: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000323a (10.7554/ELIFE.36307 )
• 5QEI: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_pktta024495b (10.7554/ELIFE.36307 )
• 5QEJ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa001247b (10.7554/ELIFE.36307 )
• 5QEK: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmoze000092b (10.7554/ELIFE.36307 )
• 5QEL: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000675b (10.7554/ELIFE.36307 )
• 5QEM: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000217b (10.7554/ELIFE.36307 )
• 5QEN: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000955b (10.7554/ELIFE.36307 )
• 5QEO: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000657b (10.7554/ELIFE.36307 )
• 5QEP: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000692b (10.7554/ELIFE.36307 )
• 5QEQ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000245b (10.7554/ELIFE.36307 )
• 5QER: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000847b (10.7554/ELIFE.36307 )
• 5QES: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000141a (10.7554/ELIFE.36307 )
• 5QET: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000017a (10.7554/ELIFE.36307 )
• 5QEU: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000149a (10.7554/ELIFE.36307 )
• 5QEV: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000603b (10.7554/ELIFE.36307 )
• 5QEW: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000470b (10.7554/ELIFE.36307 )
• 5QEX: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000123a (10.7554/ELIFE.36307 )
• 5QEY: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000708a (10.7554/ELIFE.36307 )
• 5QEZ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000713b (10.7554/ELIFE.36307 )
• 5QF0: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000216b (10.7554/ELIFE.36307 )
• 5QF1: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000272b (10.7554/ELIFE.36307 )
• 5QF2: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000187a (10.7554/ELIFE.36307 )
• 5QF3: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000194a (10.7554/ELIFE.36307 )
• 5QF4: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000144a (10.7554/ELIFE.36307 )
• 5QF5: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa001440b (10.7554/ELIFE.36307 )
• 5QF6: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000281b (10.7554/ELIFE.36307 )
• 5QF7: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000951b (10.7554/ELIFE.36307 )
• 5QF8: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000114a (10.7554/ELIFE.36307 )
• 5QF9: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000242a (10.7554/ELIFE.36307 )
• 5QFA: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000752b (10.7554/ELIFE.36307 )
• 5QFB: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_pkooa000283c (10.7554/ELIFE.36307 )
• 5QFC: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000140a (10.7554/ELIFE.36307 )
• 5QFD: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000505a (10.7554/ELIFE.36307 )
• 5QFE: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000509a (10.7554/ELIFE.36307 )
• 5QFF: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000515a (10.7554/ELIFE.36307 )
• 5QFG: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000523a (10.7554/ELIFE.36307 )
• 5QFH: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000525a (10.7554/ELIFE.36307 )
• 5QFI: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000531a (10.7554/ELIFE.36307 )
• 5QFJ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000814b (10.7554/ELIFE.36307 )
• 5QFK: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000509a (10.7554/ELIFE.36307 )
• 5QFL: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000206a (10.7554/ELIFE.36307 )
• 5QFM: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000269a (10.7554/ELIFE.36307 )
• 5QFN: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000324a (10.7554/ELIFE.36307 )
• 5QFO: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000644b (10.7554/ELIFE.36307 )
• 5QFP: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000293a (10.7554/ELIFE.36307 )
• 5QFQ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000491a (10.7554/ELIFE.36307 )
• 5QFR: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000497a (10.7554/ELIFE.36307 )
• 5QFS: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmomb000293a (10.7554/ELIFE.36307 )
• 5QFT: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000683b (10.7554/ELIFE.36307 )
• 5QFU: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000487a (10.7554/ELIFE.36307 )
• 5QFV: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000491a (10.7554/ELIFE.36307 )
• 5QFW: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000497a (10.7554/ELIFE.36307 )
• 5QFX: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000953b (10.7554/ELIFE.36307 )
• 5QFY: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000396a (10.7554/ELIFE.36307 )
• 5QFZ: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000711a (10.7554/ELIFE.36307 )
• 5QG0: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000280c (10.7554/ELIFE.36307 )
• 5QG1: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000619a (10.7554/ELIFE.36307 )
• 5QG2: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000275a (10.7554/ELIFE.36307 )
• 5QG3: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000662a (10.7554/ELIFE.36307 )
• 5QG4: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000666a (10.7554/ELIFE.36307 )
• 5QG5: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000811b (10.7554/ELIFE.36307 )
• 5QG6: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa001176b (10.7554/ELIFE.36307 )
• 5QG7: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000611a (10.7554/ELIFE.36307 )
• 5QG8: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000555a (10.7554/ELIFE.36307 )
• 5QG9: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000595a (10.7554/ELIFE.36307 )
• 5QGA: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000540a (10.7554/ELIFE.36307 )
• 5QGB: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000628a (10.7554/ELIFE.36307 )
• 5QGC: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000650a (10.7554/ELIFE.36307 )
• 5QGD: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000611a (10.7554/ELIFE.36307 )
• 5QGE: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000619a (10.7554/ELIFE.36307 )
• 5QGF: pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000539a (10.7554/ELIFE.36307 )
• 5T19: structure of ptp1b complexed with n-(3'-(1,1-dioxido-4-oxo-1,2,5- thiadiazolidin-2-yl)-4'-methyl-[1,1'-biphenyl]-4-yl)acetamide (10.1021/ACS.BIOCHEM.7B00151 )
• 6B8E: multiconformer model of apo wt ptp1b with glycerol at 180 k (10.7554/ELIFE.36307 )
• 6B8T: multiconformer model of apo wt ptp1b with glycerol at 240 k (10.7554/ELIFE.36307 )
• 6B8X: multiconformer model of apo wt ptp1b with glycerol at 278 k (10.7554/ELIFE.36307 )
• 6B8Z: multiconformer model of wt ptp1b with bb3 at 273 k (10.7554/ELIFE.36307 )
• 6B90: multiconformer model of apo wt ptp1b with glycerol at 100 k (alternative refinement of pdb 1sug showing conformational heterogeneity) (10.7554/ELIFE.36307 )
• 6B95: multiconformer model of k197c ptp1b tethered to compound 2 at 100 k (10.7554/ELIFE.36307 )
• 6BAI: multiconformer model of apo k197c ptp1b at 100 k (10.7554/ELIFE.36307 )
• 6CWU: protein tyrosine phosphatase 1b f135y mutant (10.1021/ACS.BIOCHEM.8B00656 )
• 6CWV: protein tyrosine phosphatase 1b a122s mutant (10.1021/ACS.BIOCHEM.8B00656 )
• 6NTP: ptp1b domain of ptp1b-lov2 chimera (10.1038/S41467-020-14567-8 )
• 6OL4: protein tyrosine phosphatase 1b (1-301), f182a mutant, apo state (10.1021/JACS.9B04470 )
• 6OLQ: protein tyrosine phosphatase 1b (1-301), p188a mutant, apo state (10.1021/JACS.9B04470 )
• 6OLV: protein tyrosine phosphatase 1b (1-301), p185a mutant, apo state (10.1021/JACS.9B04470 )
• 6OMY: protein tyrosine phosphatase 1b (1-301), p180a mutant, apo state (10.1021/JACS.9B04470 )
• 6PFW: protein tyrosine phosphatase 1b (1-301), t177a mutant, apo state (10.1021/JACS.9B04470 )
• 6PG0: protein tyrosine phosphatase 1b (1-301), p188a mutant, vanadate bound state (10.1021/JACS.9B04470 )
• 6PGT: protein tyrosine phosphatase 1b (1-301), t177a mutant, vanadate bound state (10.1021/JACS.9B04470 )
• 6PHA: protein tyrosine phosphatase 1b (1-301), f182a mutant, vanadate bound state (10.1021/JACS.9B04470 )
• 6PHS: protein tyrosine phosphatase 1b (1-301), p185a mutant, vanadate bound state (10.1021/JACS.9B04470 )
• 6PM8: protein tyrosine phosphatase 1b (1-301), p180a mutant, vanadate bound state (10.1021/JACS.9B04470 )
• 6W30: protein tyrosine phosphatase 1b bound to amorphadiene (10.1021/ACSSYNBIO.1C00074 )
• 6XE8: crystal structure of the ptp1b yoph wpd loop chimera 3 apo form
• 6XEA: crystal structure of the ptp1b yoph wpd loop chimera 3 bound to vanadate
• 6XED: crystal structure of the ptp1b yoph wpd loop chimera 3 bound to tungstate
• 6XEE: crystal structure of the ptp1b yoph wpd loop chimera 4 apo form
• 6XEF: crystal structure of the ptp1b yoph wpd loop chimera 4 bound to vanadate
• 6XEG: crystal structure of the ptp1b yoph wpd loop chimera 4 bound to tungstate
• 7KEN: protein tyrosine phosphatase 1b, d289a mutant, apo state (10.1021/ACS.BIOCHEM.0C00841 )
• 7KEY: protein tyrosine phosphatase 1b, apo (10.1080/07391102.2021.1994879 )
• 7KLX: protein tyrosine phosphatase 1b with inhibitor (10.1080/07391102.2021.1994879 )
• 7L0C: ligand-free ptp1b t177g (10.1021/JACSAU.1C00054 )
• 7L0H: vanadate-bound ptp1b t177g (10.1021/JACSAU.1C00054 )
• 7LFO: protein tyrosine phosphatase 1b (10.1021/ACSSYNBIO.1C00074 )
• 7MM1: ptp1b in complex with tcs401 by native s-sad at room temperature
• 7RIN: apo ptp1b by native s-sad at room temperature